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Course of acute renal failure studied by a model of creatinine kinetics.
A computerized model of creatinioe kioetics was developed to predict
the relationship between creatinine clearance [G(t)} and plasma creati-
nine concentration [C(t)] in patients with postischemic acute renal
failure (ARF). A comparison of predicted to measured values in 35
episodes of ARF in 27 patients revealed three patterns of declining G(t)
following an ischemic insult. Pattern A, characterized by an abrupt step
decrement in 0(t) following an isolated renal ischemic episode lasting
minutes or hours, was observed in nine patients. It was followed
invariably by an immediate ramp increment in 0(t), despite which C(t)
continued to increase for several days. Urinary indices during the
period of increasing azotemia were consistent with the resolving stage
of ARF. Patterns B (N = 15) and C (N = 11) were associated with
persistent renal ischemia of long (days to weeks) duration and were
respectively characterized by prolonged ramp or exponential decre-
ments in G(t). A concurrent increase in C(t) was associated with urinary
indices typical of the maintenance or sustained stage of ARF. Recovery
of 0(t) was observed in only two-thirds of patterns B and C cases and
took the form of a ramp or exponential increment. Because G(t) and
total body water were changing rapidly in ARF, changes in measured
plasma creatinine levels alone failed to identify these patterns of
deteriorating or improving renal function, However, when the compu-
terized model was used in conjunction with daily measured values of
C(t) and body weight and occasional estimates of G(t), the course and
prognosis of ARF in individual patients were illuminated.
L'évolution d'une insuflisance rénale aiguë étudiée par un modèle de
cinétique de Ia eréatinine. Un modêle sur ordinateur de cinétique de Ia
créatinine a Cté dCveloppé afin de predire la relation entre la clearance
de la créatinine [0(tjl et Ia créatininémie [C(tfl chez les malades ayant
une insuffisance rénale chronique post-ischémique (ARF). Une
comparaison des valeurs predites avec celles measurées dans 35
episodes d'ARF chez 27 malades a révdld trois types de déclin de G(t)
aprés une atteinte ischémique. Le type A, caractérisé par un
décrochement abrupt de G(t) suivant un episode isold d'ischémie rénale
durant quelques minutes ou heures, a ete observe chez neuf malades. II
était suivi invariablement par une augmentation linéaire immediate de
G(t), bien que C(t) continue a s'dlever pendant plusiers jours. Les
paramCtres urinaires pendant Ia période d'azotdmie croissante étaient
compatibles avec le stade de guérison de l'ARF. Les types B (N = 15)
et C (N = 11) étaient associés a une ischCmie rCnale persistante de
longue durCe (plusiers jours ou semaines) et étaient caractérisés respec-
tivement par des decroissances prolongées lindaires ou exponentielles
de G(t). Doe augmentation coocomitante de C(t) était associCe avec des
index urinaires typiques d'un stade d'eotretien ou de prolongation de
l'ARF. Une récupdration de G(t) était observée chez seulement les
deux tiers des cas de types B et C et prenait la forme d'une augmenta-
tion linéaire ou exponeotielle. Puisque G(t) et l'eau totale de
l'orgaoisme changeaient rapidement en ARF, les modifications de la
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concentration de creatinine plasmatique ne pouvaient pas, a elles seules,
tradiure Ia deterioration ou l'amélioration de la fonction rdnale.
Cependant, lorsque le modèle par ordinateur était utiise en association
aux valeurs mesurées journalières de C(t) et de poids corporel et a des
estimations occasionnelles de 0(t), l'évolution et Ic pronostic de l'ARF
chez ces malades, individuellement, etaient éclaircis.
Transient interruption of renal blood flow is complicated
frequently by an abrupt and profound depression of renal
excretory function known as postischemic, acute renal failure
(ARF). Serial measurements of the urinary clearance of a
filtration marker, such as inulin, have revealed two distinct
phases of renal injury [1—3]. The first or maintenance phase is
often 1 to 2 weeks' duration. Inulin clearance is depressed to 5
to 15% of normal [3—5]. The maintenance phase is followed by
a resolving phase, which is characterized by a progressive rise
of inulin clearance. Fully 8 weeks may elapse, however, before
restoration of inulin clearance to a normal range signifies
complete recovery of renal function [1].
It is noteworthy that the urinary clearance of inulin is not a
measure of the true glomerular filtration rate (GFR) in the
maintenance phase of ARF. This is because a portion of inulin
that is filtered leaks back across damaged tubular epithelium
and enters the interstitium [2, 6, 7]. Yet another portion is
sequestered in obstructed tubular lumina [8, 9]. The resolving
phase, by contrast, is characterized by restoration of tubular
impermeability to filtration markers and relief of intratubular
obstruction [1, 2]. Whereas the changing urinary clearance of a
filtration marker may better reflect GFR in the resolving phase,
it characterizes a more complex injury to the entire nephron
during the maintenance phase.
Among the small endogenous solutes that are retained in the
body water, creatinine has the properties that most closely
resemble those of a true filtration marker. Accordingly, the
duration of the maintenance phase of ARF in humans is
monitored most frequently by following the rise in plasma
creatinine concentration on a daily basis, while the resolving
phase is associated in clinical practice with a spontaneous
decline in plasma creatinine concentration from peak levels [3].
There are, however, a number of limitations to the reliability
with which the plasma creatinine concentration profile can be
used to monitor the course of renal injury in ARF. The level of
creatinine in plasma water is determined not only by its urinary
clearance but also by its rate of production and its volume of
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distribution in the body [10, 11]. In an attempt to relate the
prevailing plasma creatinine concentration to its underlying
urinary clearance by the injured kidney in ARF, we attempted
to isolate net clearance from the other variables that govern the
measured concentration of creatinine in plasma. To do this we
examined in ARF patients the relationship between plasma
creatinine concentration on the one hand and simultaneously
changing renal excretory function and body water on the other.
The resulting analysis has led to the development of a compu-
terized model which reliably predicts and quantifies changes in
the plasma concentration and urinary clearance of creatinine,
even when the underlying GFR and tubular contribution to
filtration marker clearance are changing very rapidly. The
model permits changes in the direction of global nephron
function that were unappreciated previously to be identified
readily, and in this way allows the course of ARF in individual
patients to be delineated with accuracy.
Methods
Rationale
The change () in plasma creatinine concentration with
respect to time is proportional to the rate of production minus
the rate of loss of creatinine, that is
(creatinine) a production—loss
Let Pr be the production rate of creatinine, (mg/day); and the
following be functions of time: C(t), concentration of creatinine
in plasma (mg/liter); G(t), urinary clearance of creatinine from
plasma (liter/day); TW(t), total body water (liter); C'(t), the
instantaneous rate of change of the concentration of creatinine
in plasma (mg/liter/day).
The rate of change of plasma creatinine concentration with
time may be expressed in terms of the rate of production and
excretion as modified by the volume of distribution of creati-
nine. Thus,
dC/dt = C'(t) = Pr
— G(t) C(t)
TW(t) (1)
Solving for G(t) yields
Pr — C'(t) TW(t)G(t) = _____________
C(t)
Eq. 2 shows the relationship of the determinants of creati-
nine: production, volume of distribution times the rate of
change of plasma creatinine concentration, and the simultane-
ous plasma creatinine concentration. The accuracy of a predic-
tion of GFR, minus the tubular backleak and sequestration rate
in sustained ARF, or GFR alone in resolving ARF, depends on
the knowledge of the determinants of the clearance of creatinine
and the success with which creatinine clearance simulates the
rate of clearance of a filtration marker in ARF.
For the ensuing analysis it is assumed: (1) that the production
rate of creatinine is unchanging; (2) that the volume of distribu-
tion of creatinine approximates the total body water [10]; (3)
that acute changes in total body water may be estimated from
corresponding acute changes in body weight; and (4) that
filtration marker clearance may be approximated by the clear-
ance of creatinine [G(t)].
If changes in the clearance of creatinine, G(t), are to be
estimated reliably by a mathematical model, the model should
be sufficiently flexible to account for any perturbation in G(t),
real or hypothetical. The imposition of forced perturbations in
G(t), using the relationship of Eq. (1), permits derivation of a
curve expressed by the time function C(t). Clearly, inserting
these derived values of C(t) from Eq. (1) into any model that
predicts 0(t) from changing plasma creatinine concentration
should yield the original forced perturbation in G(t). However,
when G(t) is changing rapidly this test is often failed by
previously published models [10—12]. The mathematical reason
for the failure is most often the inaccuracy in estimating the
instantaneous rate of change of plasma creatinine concentration
C'(t). Previous models have assumed a linear rise or fall in the
day-to-day concentration of creatinine [10—12]. Any actual
deviation from linearity in the rise or fall of plasma creatinine
concentration with time would clearly invalidate a subsequent
calculation of G(t). Furthermore, the aforementioned models
have assumed also that total body water is a fixed percentage of
body weight. When the percentage of body weight that is water
is changing along with G(t), such an assumption compounds the
error in computing the urinary clearance of creatinine.
Accordingly, we have modified earlier models of creatinine
kinetics [10—12] by examining the effects on changes in C(t) that
result from a variety of forced perturbations of G(t). Appendix
I details solutions for three differing decremental and three
corresponding incremental perturbations of G(t). Each of these
six changes in G(t) and the corresponding predicted pattern of
change in C(t) are shown in Figure 1. The left upper panel (A) in
Figure 1 represents a step decrement in 0(t); the pattern of
change in C(t) is a curve which is concave downward. A ramp
decrement in G(t) shown in panel B by contrast produces a
pattern of change in C(t) which is sigmoidal in shape. Only
when the decrement in G(t) is proportional to 1/time, as in panel
C, is the pattern of rise in C(t) linear. The effects on C(t) of
increasing G(t) where the latter occurs in a step increment
(panel D), ramp increment (panel E) or an increment propor-
tional to 1/time (panel F), can be seen to produce patterns that
are almost mirror images of the corresponding decrements of
0(t) (Fig. 1). We have also considered a seventh perturbation
which combines a decremental step change in G(t) followed by
a mathematically dissimilar ramp increment as depicted in
Figure 2. The solution for this more complex perturbation of
G(t) is given in Appendix 2.
Development of a computerized model of creatinine kinetics
The functional relationship between the urinary clearance
and plasma concentration of creatinine is Eq. 2. To permit
clinical recognition and quantification of changes in G(t), a
computer program was written based on Eq. 2. The program
was then tested by assessing its ability to reproduce the seven
hypothetical perturbations of 0(t) illustrated in Figures 1 and 2,
that is, decrements, increments, and a combination of both.
The ability of the model to chart the actual course of ARF
was next examined in 27 patients with hemodynamically medi-
ated renal insufficiency. Daily measurements of plasma creati-
nine concentration and body weight were recorded for 7 to 27
days from the time of ischemic insult in each patient. During
this period timed 2 to 4 hr urine collections were made through
an indwelling bladder catheter. Blood was sampled at the
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midpoint of the urine collection to permit the determination of
the creatinine clearance. The number of creatinine clearance
determinations obtained in this fashion varied from 3 to 20 per
patient. To enhance the clinical application of the program,
maximal individualization of input data was attempted. The
creatinine production rate was estimated in five instances from
measurements of the urinary creatinine excretion rate made
prior to the development of ARF. In the remaining subjects
creatinine production was calculated from the following
formula
Pr = (120 — 1.0 x age) x baseline weight ÷ 5
where age refers to patient age. (This formulation reflects
Jeliffe's modification of Siersback-Nielsen's equation. [11, 13])
Conventional estimates of total body water based on body
weight (60% males, 55% females) were modified by a clinical
appraisal of hyper- or hypovolemia, fixed as plus or minus 10%
of body water. Rather than assuming that total body water
remains a fixed percentage of body weight, subsequent net
changes from baseline in body water were equated with mea-
sured daily changes in body weight. For example, a 70-kg man
is assumed to have 70 x 60% = 42 liters of body water. If body
weight were to increase 3 kg in 24 hr because of fluid intake
100
E
exceeding output, then total body water would be 42 + 3 = 45
liters and body water as a percentage of weight would increase
to (42 + 3) ÷ (70 + 3) = 45/73 = 62%. Note, however, that the
absolute increment in body water is 3/42 = 7%.
A "normalized" plasma concentration of creatinine [C(t)]
was determined from the curve of the actual concentration
corrected for changes in total body water. The rate of change of
creatinine concentration was determined by using a computer
technique developed to estimate more accurately this determi-
nant of G(t). The technique incorporates the changes in plasma
creatinine concentration from measurements both preceding
and following the point of interest so as to adjust the estimated
slope of the plasma creatinine concentration curve for
nonlinearity. The program samples the input data and ignores
minor changes in plasma creatinine concentration (± 0.1 mg/dl)
attributable to laboratory error. For creatinine kinetic calcula-
tions, the computer was an Apple lie (64K RAM, Apple
Computer, Inc., Cupertino, California, USA). The computer
language was BASIC (Applesoft floating point). Curve fitting
was performed with a Hewlett-Packard computer (Model 97,
(3 Hewlett-Packard, Elkhart, Indiana, USA). An acceptable fitwas defined as r greater than or equal to 0.9.
Clinical evaluation of acute renal failure
Of the 27 members of the study population, 21 developed
ARF following cardiac surgery, while ARF in the remainder
occurred in the wake of surgical repair of a diseased upper
(suprarenal) abdominal aorta. The ARF was characterized in
each instance by an evaluation of indices that we described
previously [5] and that included the urine flow rate, the urinary
clearance of inulin, the fractional excretion of sodium, and the
urine-to-plasma concentration ratios of inulin, and total solutes.
These indices of ARF were determined in each instance during
I I Illl 'I' I
(A) Step decrement (D) Step increment
G(t)
C(t(
(B) Ramp decrement (E) Ramp incrementG(t(
C)t)
(C) Decrement a 1/time (F) Increment a (1—1/time)
C)t) C(t)
Fig. 1. Hypothetical perturbations of creatinine clearance [G(t)] and
accompanying alteration of plasma crearinine concentration [C(t)I.
Three differing decrements of G(t) are on the left, corresponding
increments are on the right. Although not shown, both values are
plotted as a function of time.
10 -
111111 liii I
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Time. days
Fig. 2. Effect of hypothetical step decrement followed by ramp incre-
ment in creatinine clearance [G(t)] on plasma creatinine concentration
IC(t)]. Note each value is plotted as a function of time in days.
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Table 1. Imposed versus predicted changes in 0(t)
Dccrements in G(t), mI/mm
Time
hr
Increments in 0(t), mI/mm
D Step
Imposed Predicted
E Ramp
Imposed Predicted
F Inve
Imposed
rse time
Predicted
Time
hr
A Step
Imposed Predicted
B Ramp
Imposed Predicted
C Inve
Imposed
rse time
Predicted
—12
0
12
24
36
48
120
10
10
10
10
10
120
5
5
6
7
8
120 120
120 120
93 95
65 67
38 42
10 14
120
120
26
24
22
20
120
120
30
26
23
21
—12
0
12
24
36
48
10
120
120
120
120
120
10
130
130
130
126
123
12 12
12 12
30 27
48 45
66 63
84 82
10
10
46
65
76
90
10
10
43
63
74
89
E
0C
0
C
C
0)
Table 2. Imposed versus predicted 0(t) with step decrement followed
by ramp increment
G(t), mI/mm
Day Imposed Predicted
—1
0
1
2
3
4
120
0
40
80
120
120
120
5
36
76
126
122
80 - 7
:::
20 - :
10
I I I I I
0 10 20 30 40 50 60 70 80
Calculated creatinine clearance, mi/mm
Fig. 3. Correlation of measured values of creatinine clearance with
those predicted by the kinetic model. The data points represent 180
estimations made prior to or during the acute renal failure in 27
subjects. The regression and identity lines are depicted by solid and
broken lines, respectively.
ARF, while two or three distinct episodes were observed in
each of the remaining six patients. A total of 180 measurements
of creatinine clearance were made in these 27 patients during
the course of their ARF. These measured clearances are
compared in Figure 3 to simultaneous clearances of creatinine
calculated by the model. Linear regression analysis revealed
the calculated and measured clearances to be correlated
strongly with a correlation coefficient of 0.933. From examina-
tion of the line of identity in Figure 3, it can be seen that
calculated clearances slightly overestimated the measured
clearances in a majority of instances. The opposite was true for
a minority of calculated clearances which tended to under-
estimate measured clearances. It is important to emphasize,
however, that the disparity tended to remain constant for
repeated comparisons in a given patient. Thus, irrespective of
the source of the small systematic error between measured and
calculated clearances, the consistency of the disparity in indi-
vidual patients permits the direction and magnitude of changes
in ARF to be recognized and quantitated with accuracy.
Nine episodes of ARF were associated with the step decre-
ment of 0(t) illustrated in panel A of Figure 1. A ramp
decrement (panel B) and inverse time decrement (panel C) were
a period of increasing azotemia that preceded the attainment of
peak concentration of creatinine in plasma. In 5 of the 27
patients the indices were remeasured during the resolving stage
of ARF when the plasma concentration of creatinine was
declining.
The concentration of creatinine in urine and plasma was
determined by an automated, rate-dependent picrate method,
using a creatinine analyzer (analyzer II, Beckman Instruments,
Fullerton, California, USA). This method minimizes the influ-
ence of slowly reacting, noncreatinine chromogens, and thus
provides an estimate of true creatinine concentration in plasma
[14]. Inulin concentration was determined by the autoanalyzer
method of Fjeldbo and Stamey [15]. Osmolality of urine and
plasma was measured directly using an osmometer (Model 332,
Advanced), while the corresponding concentrations of sodium
were determined by flame photometry.
Results
Response of the model to hypothetical perturbations of G(t)
Displayed in Table 1 is the model's response to the perturba-
tions depicted in Figure 1. In a hypothetical patient in whom
G(t) declines to 10% of normal because of ARF, the current
model predicts with accuracy the direction and magnitude of
the forced perturbations of 0(t). Errors in determining the
direction of change in 0(t) do not occur. Errors in estimating
the magnitude of change are usually small, averaging a few
milliliters per minute. The seventh comparison, to the combina-
tion of step decrement and ramp increment of Figure 2, is
shown in Table 2. With the model's more accurate estimation of
the instantaneous rate of change of plasma creatinine concen-
tration, even a very labile G(t) can be monitored with accuracy.
Analysis of data in patients with acute renal failure
There were 35 episodes of acute renal insufficiency in the 27
patients studied. Twenty-one patients had a single episode of
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1 (A) 0 9 0 0 100
II (B) 0 7 3 5 67
III (C) 0 3 4 4 64
observed in 15 and II episodes, respectively. These three
patterns of declining G(t) were then used in categorizing ARF as
types I, II, and 111, respectively.
The ensuing recovery patterns are summarized in Table 3.
Nineteen episodes of recovering G(t) were characterized by a
ramp increment (Fig. 1, panel E) while an additional seven
recovery episodes followed an inverse time incremental pattern
(Fig. 1, panel F). A step increment in G(t) (Fig. 1, panel D) was
not observed in this group of patients. Without exception all of
the patients having type I injury (step decrement) recovered in
a pattern reflected by a ramp improvement in G(t). The pattern
of recovery was more variable in types II and III injury,
including examples of both patterns E and F (Table 3). Of note,
five of six patients having more than one episode of ARF failed
ultimately to recover renal function. An example of the patterns
of loss and recovery of G(t) is illustrated for patients repre-
sentative of each of the three types of renal injury in Figure 4.
As may be clearly seen, there was a remarkable concordance (r
> 0.9) between the profiles of plasma creatinine concentration
and creatinine clearance actually exhibited by our patients and
the hypothetical plots displayed in Figures 1 and 2.
Correlates of injury patterns
Using the aforementioned indices of glomerular and tubular
functions to characterize ARF revealed that type I injury has
striking differences compared with types II and III injury,
respectively. For the sake of convenience Table 4 compares the
urinary indices in these three categories of ARF to correspond-
ing values for patients making an uncomplicated and
nonazotemic recovery from cardiac surgery (control group 1)
and to values typical of patients recovering from postcardiac
surgical ARF (control group 2). The data from each of these two
"control" comparison groups are from an earlier study by us
that has been reported in detail elsewhere [5].
Compared to group I "normal" controls, glomerular and
tubular functions were considerably deranged with all three
types of ARF. However, type I [step decrement in G(t)1 differed
from type II [ramp decrementi and III [inverse time decrement]
in that with the former, inulin clearance was threefold higher
while the ability to form a concentrated urine was relatively
preserved (Table 4). Judged by a lower fractional excretion of
sodium and higher urine-to-plasma inulin concentration ratio,
the fractions of filtered sodium and water reabsorbed in type I
ARF were also substantially higher than corresponding values
in types II and III ARF (Table 4). Although plasma creatinine
concentration was rising sharply at the time that these urinary
indices were determined in type I ARF, a ramp type recovery of
G(t) was already underway (Fig. 4 panels A and D). That the
superior glomerular and tubular functions observed in the type
I injury appear to reflect the resolving stage of ARF is sup-
ported by the data in Table 4. There is a striking resemblance of
urinary indices of type 1 ARF to those of control group 2 with
50
40
30
E
20
10
0
2 /
0L
0 2 4 6 8 10 0 2 4 6 8 10 12
Days Days
Fig. 4. Computed (solid lines) versus measured individual data points in
four individual patients who display the patterns of loss and recovery of
crealinine clearance depicted in Figure 1. Values for plasma creatinine
concentration, [C(t)] are in the upper panel; corresponding values for
creatinine clearance [G(t)] are in the lower panel. Patient A demon-
strates pattern A step decrement followed by pattern E ramp increment
of G(t). Patient B demonstrates pattern B ramp decrement followed by
pattern F ramp increment. Patient C demonstrates pattern C I/time
decrement with no ensuing recovery. Patient D had two episodes of G(t)
loss, pattern B and A, respectively, followed by pattern F (1/time) and
then pattern E recovery.
recovering ARF, and also to those of the five patients of the
present study who were recovering from types II and 111 ARF.
The ischemic insult underlying the ARF also differed strik-
ingly between type I ARF and types II and III ARF. With the
former, the patients appeared to sustain a single insult during
surgery and experienced an uneventful postoperative course
free of hemodynamic compromise. This was evidenced in type
I patients by the fact that the treating surgeons had removed
Swan-Ganz catheters and central venous lines by the time the
urinary indices of ARF were determined (day 3 2, mean
sEM). In types II and III patients by contrast, the p stoperative
course was characterized by prolonged cardiac dysfunction.
Table 3. Type of recovery
Type of ARF (Pattern) (D) (F) (F) None % Recovered
CA
E
C,
6
4
C(t)
0
G(t)
D
02468
B
E
C)
8
8
6
4
21
0
90
80
70
60
50
40
30
20
10
60
50
40
30
20
10
0 llllI'll
Recovering ARF
Type II, III 5 28 7
Creatinine in acute renal failure 933
Table 4. Functional indices in three types (patterns) of acute renal failure°
a All results are reported as a mean 1 SE; one patient with both types II and III ARF had physiological studies performed in each.
' was not measured.
P < 0.05 vs. type I.
d 0.05 <P < 0.1 vs. type I.
Thus, at the time of measurement of urinary indices (postopera-
tive day 7 1, range 4 to 12), all 18 patients were receiving
inotropic agents and undergoing intravascular hemodynamic
monitoring. Cardiac performance in five of these 18 patients
required additional augmentation with an intra-aortic balloon
pump. In all but one of six patients in whom cardiac output was
determined at the time of measurement of urinary indices, the
former value was depressed below 4 liters/mm. The super-
imposition of other insults upon the poor cardiac performance,
including administration of nephrotoxic drugs and contrast
agents, and brief episodes of hypotension related to cardiac
arrhythmias or hypovolemia, were observed commonly in types
II and III but never in type I ARF. It appears then that type I
injury occurs in the wake of a brief and isolated ischemic renal
insult and is followed rapidly and invariably by recovery. Types
II and III injury by contrast, appear to ensue after prolonged,
and sometimes repeated, episodes of renal ischemia and to
manifest a failure of recovery in a substantial subset of patients
(Table 3).
Discussion
Serial determinations of the clearance of inulin have proven
useful in charting the course and outcome of postischemic ARF
[1, 31. Unlike inulin, creatinine is cleared from plasma into urine
not only by glomerular filtration but also by tubular secretion
1161. Judged by the observed, average creatinine-to-inulin clear-
ance ratios of 1.3 to 1.6 (Table 4), the normal predominance of
glomerular creatinine filtration over creatinine tubular secretion
appears to be true also of the kidney injured by ARF. As
discussed previously, the lowered inulin clearance of ARF may
be ascribed, in part, to transtubular backleak of inulin 12, 6, 71.
Because inulin backleak is passive (that is, occurs solely by
ultrafiltration and/or diffusion through the damaged tubule
wall), filtered creatinine, with its smaller size and molecular
weight (113 vs. 5200 daltons for inulin) should leak back with at
least equal facility. The opposing contributions to the urinary
clearance from passive backleak and active secretion of creati-
nine must remain conjectural. Nevertheless, we note with
interest that the creatinine-to-inulin clearance ratio in all three
categories of ARF encountered in the present study (ito III), as
well as during recovery in an earlier study, is relatively constant
(Table 4). Given this parallel relationship with inulin clearance,
we propose that the utility of the creatinine clearance to detect
rapid alterations in global renal function should be perfectly
adequate for clinical purposes. As this study clearly demon-
strates, changes in creatinine clearance during ARF are indeed
common and measurable. Moreover, the accuracy of the as-
sessment of both the magnitude and direction of such changes
may be improved by the simultaneous use of standard creati-
nine clearance techniques and the proposed, computerized
analysis of creatinine kinetics.
Our reformulation of creatinine kinetics in ARF and the
aforementioned analysis of forced perturbations of creatinine
clearance reveal a number of findings that are at once somewhat
surprising and of considerable clinical import. The common
perception is that a rising level of plasma creatinine is synony-
mous with a falling glomerular filtration rate, and that the
converse is true of a declining plasma creatinine concentration.
However, a re-examination of Figure 1 reveals that the antici-
pated, inverse relationship between these two quantities may be
dissociated. As shown in panels A through E, plasma creatinine
concentration may rise or fall when G(t) is unchanging. The
most surprising finding, shown in Figure 2 and demonstrated by
nine of our patients, is that the concentration of creatinine may
be increasing rapidly while G(t) is actually rising. Clearly, a
knowledge of nephron function in ARF demands an approach
which examines more than the simple day-to-day variation in
the plasma concentration of creatinine.
Our computerized analysis provides other insights which are
pertinent to patient care. Following an acute insult which
results in increasing azotemia, the number of days during which
creatinine continues to rise is of prognostic value. A re-
examination of Figure 1 illustrates this point. According to our
computations, progressive increases in plasma creatinine con-
centration of greater than 5 days' duration are characteristic of
ARF in which recovery has not begun or is quantitatively
insignificant; examples are shown in panels A, B, and C.
However, as depicted in Figure 2, a profound step decrement in
renal excretory function followed immediately by gradual re-
covery over 7 days is computed to result in a plasma creatinine
N mi/mm
Cnuiin V
84 8Control group 1 44
ARF Type I
Type II
Type III
9
10
9
30 3
12 20
9 I'
Control group 2
(Recovering) 10 29 3
U/Posm U/Pin FENA
U /Pcreat
UIPn
1.8 0.5 1.9 0.1 68 9 1.3 0.4 1.3 0.1
1.7 0.3
1.1 0.30
1.6 0.2
1.4 0.1
1.0 0.010
1.0 0.010
16 4
10 -- 3
7 ÷
0.8 0.2
6.8 2.10
10.7 2.70
1.4 0.1
1.5 0.1
1.6 0,1
1.5 0.1 1.3 0.1 22 ÷ 4 1.4 0.6 1.3 0.1
1.6 0.2 1.3 0.1 47 5 0.8 0.2 N/A"
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Table 5. Effects of increasing total body water on serum creatinine concentration in ARF
Day
Creatinine
clearance
mI/mm
Weight
kg
Total body
water
liters
Laboratorya
creatinine
mg/dl
Corrected"
creatinine
mg/dI
Total body
water
weight, %
Patient (A) —1
0
1
2
3
44
44
37
35
29
68
68
80.4
82
82.5
40.8
40.8
53.2
54.8
55.3
1.4
1.4
1.2
1,1
1.4
1.4
1.4
1.6
1.5
1.9
60
60
66
67
67
Patient (B) —1
0
1
3
6
10
38
38
11
12
5
5
50.4
52
58
65
67,5
69.4
27.7
29.3
35.3
42.3
44.8
46.7
0.9
0.9
1.2
1.6
2.0
3.9
0.9
1.0
1.5
2.3
3.1
6.2
55
56
61
65
66
67
The values are measured values.
b The computed value was normalized for the increasing body water.
concentration that peaks on day 4. Even if recovery were to be
more gradual, requiring 14 days instead of 7, we calculate that
plasma creatinine concentration would nonetheless peak on
approximately day 4 post injury, albeit at a higher level. Thus,
if plasma creatinine concentration is still increasing 4 or more
days after rising azotemia is noted, the clinician may be
reasonably certain that recovery of renal function has not yet
begun. Under these circumstances, anticipation of a prolonged
period of sustained ARF and clinical planning for dialytic
support would be prudent.
The analysis of creatinine kinetics described here is novel in
that it makes allowances for the unsteady state that character-
izes acute renal failure. An important departure from previous
analyses is that the effect of rapidly increasing body water on
the concentration of plasma creatinine is considered. Two
examples of the effects of augmentation of body water caused
by fluid administration in excess of losses in two of our patients
with ARF are depicted in Table 5. In patient A a rise in plasma
creatinine concentration was completely offset by the simulta-
neous increase in total body water. To the contrary, an appar-
ent fall in plasma creatinine concentration in patient A gave the
misleading impression that renal function was improving. In
patient B of Table 5, although the rise in plasma creatinine was
not made occult, it was considerably blunted by progressive
hypervolemia, suggesting that the renal injury was less serious
than in reality. As shown in Table 5, the percentage of body
weight which was water was increasing progressively with time
in both instances. These two examples serve to emphasize that
it is incorrect to apply fixed percentages of body weight in
calculating body water when daily weight is changing due to
fluid overloading.
The present analysis also differs from previous approaches in
that the instantaneous rate of change of plasma creatinine
concentration is calculated as a function of simultaneous
changes in G(t) and in several of its determinants [Eq. (2)1.One
previous analysis [11] has related changing 0(t) to changing
plasma creatinine concentration in ARF by assuming (1) that
the rate of change of creatinine concentration in plasma is
approximated adequately by the difference in measured creati-
nine concentrations separated by intervals of 24 hr or more, and
(2) that these long intervals between successive measurements
of creatinine concentration in plasma would introduce no
significant error into the calculation of G(t) [11]. That these
earlier assumptions may be the source of considerable error in
the estimation of changing nephron function in ARF is il-
lustrated by an examination of panel D in Figure 4. On days 5,
8, and 13 postinjury, the measurements of concentration of
creatinine in plasma normalized for changing body water are
identical, 2.0 mg/dl. In the absence of intervening measure-
ments, the above-mentioned analysis would suggest that G(t)
had remained constant, when such was clearly not the case in
this patient who manifested a profound fall followed by a
progressive rise in renal function during the interim.
The single determinant of G(t) that was not modified from
earlier formulations in the present study was the production
rate of creatinine. Although the production rate of creatinine
may decline with chronic renal insufficiency [17], there have
been no studies of the stability of creatinine production during
postischemic ARF. Our assumption of an unchanging rather
than an increase or decrease of creatinine production rate may
account for the systematic error observed between calculated
and measured creatinine clearance (Fig. 3). As noted previ-
ously, however, the excellent correlation between these mea-
sured and calculated values suggests that any over- or under-
estimation of creatinine's production does not impair the ability
of the present kinetic model to detect and quantify the direction
and magnitude of changes in 0(t).
In addition to its clinical utility, the present model of creati-
nine kinetics has also provided intriguing insights into the
pathophysiology and pathogenesis of postischemic ARF. This
is particularly true of type I injury, which is revealed to be most
consistent with a postischemic step decrement followed almost
immediately by a ramp increment of filtration marker clearance.
The brevity of the maintenance phase of ARF implicit in type I
renal injury is typical of analogues of postischemic ARF in
experimental animals when prophylactic mannitol has been
administered prior to the ischemic insult [18—21], as it was to
each subject of the present study. Recovery of filtration marker
clearance within 24 hr of a transient episode of complete renal
ischemia has also been demonstrated by us previously in
mannitol-protected humans [22]. Determination of urinary indi-
ces during the stage of early resolution of ARF reveals an ability
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Step decrement
G(t) G(O)
= G(O)/N
C(t) = C(O)
= N C(O) — (N — 1) C(O)
exp[—G(O)/(N TW)] t
t0
t >0, N> 1t0
t>0
Ramp decrement
G(t)=G(O) t0
= {{G(O)IN — G(O)] ÷ t + G(O)
= G(O)IN
C(t) = C(O)
C()_k1fexPZdt k4—
expZ +expZ
G(O) C(O)Where ki = TW
k2 - G(O)/N - G(O)—
•TW
k G(O)TW
k4 = C(O)
and Z t2 + k3 t
G(O) C(O)Where Z =
G(O) + TW
0<t"t
K
+
exp{f[G(t) ÷ TW(t)]} dt (8)
Whether Eq. 8 can be expressed in simple form depends on
the integratability of the enclosed terms. As will be demonstrat-
ed, the function G(t) is the primary determinant of the final form
of C(t).
Each of the six single changes in G(t), three decrements and
three corresponding increments, will be used to solve for the
respective C(t) functions.
(Refer to Fig. lA)
(Refer to Fig. lB)
of the recovering tubules to concentrate the urine and to
conserve water and sodium (Table 4). Traditionally, these
findings have been used to distinguish patients with so-called
"prerenal azotemia" from those with established intrinsic
ARF, in which the ability to concentrate the urine and conserve
sodium is lost [23, 24]. In the present study, plasma creatinine
concentration continued to rise for several days after the
resolving stage had begun (Figs. 2 and 4). It is easy to see,
therefore, how prerenal azotemia might be confused with
recovering type I ARF in a clinical setting of recent renal
ischemia. The use of creatinine kinetics permits these two very
different entities to be distinguished readily.
Our analysis also suggests that the postischemic ramp or
inverse time decrement of types II and III injury, respectively,
are typified by long sustained renal ischemia (days) and a
protracted course of ARF. When the prolonged ischemia that
appears to underlie types II and III injury is complicated by
additional renal insults, a particularly unfavorable outcome,
nonresolution of ARF, is likely to ensue (Table 3). The use of
our computerized model to identify types II or III injury and to
detect recurring renal insults might prove useful under these
circumstances. Vigorous measures to stabilize renal perfusion,
and the scrupulous avoidance of nephrotoxic substances in this
setting, may prove efficacious in preventing an ultimate and
irreversible loss of renal function.
Appendix 1
The rate of change with time in the concentration [C'(t)} of a
marker of glomerular filtration, for example, e.g. creatinine, is
represented by the following equation:
C'(t) = [Pr -- TW(t)] — [G(t) . C(t) ÷ TW(t)] (1)
Where Pr, TW(t), G(t), and C(t) are as defined in Methods.
Rearranging Eq. 1 yields,
C'(t) + [G(t) ÷ TW(t)J . C(t) = Pr ÷ TW(t) (2)
Eq. 2 is an ordinary differential equation of the form
y'+Ay=B (3)
whereA and B are functions of time. Eq. 3 may often be solved
formally by employing a "multiplier function" of the form exp
(fA dt). Multiplying both sides of Eq. 3 by this function yields,
y' exp(fA dt) + y A exp(fA dt) = B exp(fA dt) (4)
The left side of Eq. 4 may be expressed as
d [y . exp(JA dt)] = y' exp(fA dt) + y A exp(fA dt)
Thus,
d [y exp(fA dt)] = B exp(f A dt) (5)
Integrating both sides of Eq. 5 yields,
y exp(f A dt) = fB . exp(JA dt) dt + K
where K is a constant of integration. Rearranging Eq. 6 yields,
fB . exp(fA dt) . dt + Ky
exp(f A dt) exp(fA dt)
Thus the solution to Eq. 1 assumes the form of Eq. 7
ct f[Pr ÷ TW(t)] . exp{f[G(t) ÷ TW(t)]} dt
exp{f[G(t) + TW(t)]}. dt
Where = the number of days required for G(t) to decline from
G(O) to G(O)IN.
t0
Finally,
C(t) = N C(O) — (N — 1)• C(O) . exp{—G(O)/(N . TW)1 .t t 
Decrement l/t (Refer to Fig. 1C)
G(t)=G(O) t0
(6) t>ol+t
C(t)=C(O) t0
[C(O) — Z]= Z (1 + t) + (1 + t)G(O)ITW > 0
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(Refer to Fig. 1D) Appendix 2
G(T) = G(O)) t Step decrement and linear recovery
=NG(O) t>0,N>1
C(t) = C(O) t G(t) = G(O) t < 0
=0(O)/N t=O,N>1
= + {G(O) — 0(O)/N] t/ 0 < t <
=G(O) tl
C(t)=C(O) tO
where ki, ki, k3, k4, and Z are defined as for ramp recovery,
Appendix 1.
Finally,
C(t) = C(O) + (N — 1) C(O) exp(—G(O) t/TW) t>
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